An external ventricular drainage catheter impregnated with rifampicin, trimethoprim and triclosan, with extended activity against MDR Gram-negative bacteria: an in vitro and in vivo study

Abstract Background External ventricular drainage (EVD) carries a high risk of ventriculitis, increasingly caused by MDR Gram-negative bacteria such as Escherichia coli and Acinetobacter baumannii. Existing antimicrobial EVD catheters are not effective against these, and we have developed a catheter with activity against MDR bacteria and demonstrated the safety of the new formulation for use in the brain. Objectives Our aim was to determine the ability of a newly formulated impregnated EVD catheters to withstand challenge with MDR Gram-negative bacteria and to obtain information about its safety for use in the CNS. Methods Catheters impregnated with three antimicrobials (rifampicin, trimethoprim and triclosan) were challenged in flow conditions at four weekly timepoints with high doses of MDR bacteria, including MRSA and Acinetobacter, and monitored for bacterial colonization. Catheter segments were also inserted intracerebrally into Wistar rats, which were monitored for clinical and behavioural change, and weight loss. Brains were removed after either 1 week or 4 weeks, and examined for evidence of inflammation and toxicity. Results Control catheters colonized quickly after the first challenge, while no colonization occurred in the impregnated catheters even after the 4 week challenge. Animals receiving the antimicrobial segments behaved normally and gained weight as expected. Neurohistochemistry revealed only surgical trauma and no evidence of neurotoxicity. Conclusions The antimicrobial catheter appears to withstand bacterial challenge for at least 4 weeks, suggesting that it might offer protection against infection with MDR Gram-negative bacteria in patients undergoing EVD. It also appears to be safe for use in the CNS.

[1]  M. G. Oliveira,et al.  An effective and biocompatible antibiofilm coating for central venous catheter. , 2015, Canadian journal of microbiology.

[2]  Phillip J. Bergen,et al.  Synergistic Activity of Colistin and Rifampin Combination against Multidrug-Resistant Acinetobacter baumannii in an In Vitro Pharmacokinetic/Pharmacodynamic Model , 2013, Antimicrobial Agents and Chemotherapy.

[3]  E. Connolly,et al.  Rates and determinants of ventriculostomy-related infections during a hospital transition to use of antibiotic-coated external ventricular drains. , 2013, Neurosurgical focus.

[4]  S. Patole,et al.  Antibiotic-impregnated catheters for the prevention of CSF shunt infections: a systematic review and meta-analysis , 2012, British journal of neurosurgery.

[5]  W. Marsh,et al.  Strategies to Decrease the Risk of Ventricular Catheter Infections: A Review of the Evidence , 2012, Neurocritical Care.

[6]  R. Bayston,et al.  Antibiotic resistant infections with antibiotic-impregnated Bactiseal catheters for ventriculoperitoneal shunts , 2011, British Journal of Neurosurgery.

[7]  J. Pannek,et al.  [Clinical utility of an antimicrobial blocking solution in patients with an indwelling catheter]. , 2011, Aktuelle Urologie.

[8]  Srinivas K. Prasad,et al.  Impact of a Standardized Protocol and Antibiotic‐Impregnated Catheters on Ventriculostomy Infection Rates in Cerebrovascular Patients , 2010, Neurosurgery.

[9]  R. Gutiérrez-González,et al.  Do antibiotic-impregnated catheters prevent infection in CSF diversion procedures? Review of the literature. , 2010, The Journal of infection.

[10]  C. Elwood,et al.  Use of triclosan-eluting ureteral stents in patients with long-term stents. , 2009, Journal of endourology.

[11]  Roger Bayston,et al.  An antimicrobial modified silicone peritoneal catheter with activity against both Gram-positive and Gram-negative bacteria. , 2009, Biomaterials.

[12]  D. Paterson,et al.  Management of meningitis due to antibiotic-resistant Acinetobacter species. , 2009, The Lancet. Infectious diseases.

[13]  M. Bassetti,et al.  Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections. , 2007, The Journal of antimicrobial chemotherapy.

[14]  S. Bojanić,et al.  External ventricular drain infection: the effect of a strict protocol on infection rates and a review of the literature , 2006, British journal of neurosurgery.

[15]  P. Hsueh,et al.  Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991–2003 at a university hospital in Taiwan , 2005, International Journal of Antimicrobial Agents.

[16]  J. Olson,et al.  Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. , 2003, Journal of neurosurgery.

[17]  W. Poon,et al.  Failure of regular external ventricular drain exchange to reduce cerebrospinal fluid infection: result of a randomised controlled trial , 2002, Journal of neurology, neurosurgery, and psychiatry.

[18]  T. Barbolt Chemistry and safety of triclosan, and its use as an antimicrobial coating on Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 suture with triclosan). , 2002, Surgical infections.

[19]  Xilin Zhao,et al.  Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  F. Schildberg,et al.  The prevention and treatment of vascular graft infection with a Triclosan (Irgasan)-bonded Dacron graft: an experimental study in the pig. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[21]  J. Newman,et al.  Triclosan: a review of effectiveness and safety in health care settings. , 2000, American journal of infection control.

[22]  J. Barr,et al.  In-vitro activity of the combination of colistin and rifampicin against multidrug-resistant strains of Acinetobacter baumannii. , 1998, The Journal of antimicrobial chemotherapy.

[23]  R. Bayston,et al.  Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. , 1997, Journal of neurosurgery.

[24]  R. Bayston,et al.  Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. , 1989, Journal of neurology, neurosurgery, and psychiatry.